Integration of congenital cytomegalovirus screening within a newborn hearing screening programme
Journal of Paediatrics and Child Health2019Vol. 55(11), pp. 1381–1388
Citations Over TimeTop 10% of 2019 papers
Rachael Beswick, Michael David, Hideki Higashi, Delene Thomas, Clare Nourse, Guan Koh, Pieter Koorts, Luke Jardine, Julia Clark
Abstract
Incorporating cCMV testing into Universal Newborn Hearing Screening within Queensland is realistic and achievable, both practically and financially.
Related Papers
- → Cytomegalovirus in Solid Organ Transplant Recipients: Clinical Updates, Challenges and Future Directions(2020)25 cited
- → PREEMPTIVE VALGANCICLOVIR THERAPY IS NOT ASSOCIATED WITH INCREASE IN CYTOMEGALOVIRUS (CMV) DNA IN RENAL ALLOGRAFT BIOPSY SPECIMENS COMPARED WITH VALACYCLOVIR PROPHYLAXIS(2008)4 cited
- → PREEMPTIVE THERAPY WITH VALGANCICLOVIR FOR CYTOMEGALOVIRUS-SERONEGATIVE LIVER TRANSPLANT RECIPIENTS OF CYTOMEGALOVIRUS-SEROPOSITIVE ALLOGRAFTS: A SINGLE CENTER EXPERIENCE(2010)
- → 123: The Influence of Valganciclovir Prophylaxis on Cytomegalovirus Infection after Lung Transplantation(2008)
- → EFFICACY OF PREEMPTIVE THERAPY WITH VALGANCICLOVIR FOR CYTOMEGALOVIRUS (CMV) IN CMV-SERONEGATIVE LIVER TRANSPLANT RECIPIENTS WITH CMV-SEROPOSITIVE DONORS (R???/D+).(2006)